Hugo’s work focuses on the Value, Pricing & Access strategy practice area, specializing in generation of pricing and contracting strategies for pharmaceutical and biotech clients across both US and international markets.
He has extensive experience in developing access strategies for therapies in both inpatient and outpatient settings, at all stages of the product lifecycle. Recent projects have covered a range of therapeutic areas including inflammation and immunology, rare diseases, and vaccines. Hugo joined the Putnam London office at its inception in 2020. Prior to joining Putnam, he worked for Monitor Deloitte, focusing on healthcare strategy across a broad range of public and private sector clients. Hugo holds a BA in Philosophy, Politics and Economics from the University of Oxford.